Log in

NASDAQ:SIBN - SI-Bone Stock Price, Forecast & News

$20.61
+0.02 (+0.10 %)
(As of 02/16/2020 04:00 PM ET)
Add
Today's Range
$20.29
Now: $20.61
$20.83
50-Day Range
$20.59
MA: $21.48
$22.67
52-Week Range
$14.08
Now: $20.61
$23.10
Volume85,071 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
SI-BONE, Inc., a medical device company, develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. It offers iFuse, an implant system to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. The company was founded in 2008 and is headquartered in Santa Clara, California.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:SIBN
CUSIPN/A
CIKN/A
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees183
Next Earnings Date3/5/2020 (Estimated)
OptionableNot Optionable

Receive SIBN News and Ratings via Email

Sign-up to receive the latest news and ratings for SIBN and its competitors with MarketBeat's FREE daily newsletter.


SI-Bone (NASDAQ:SIBN) Frequently Asked Questions

What is SI-Bone's stock symbol?

SI-Bone trades on the NASDAQ under the ticker symbol "SIBN."

How were SI-Bone's earnings last quarter?

SI-Bone Inc (NASDAQ:SIBN) announced its quarterly earnings data on Monday, November, 11th. The company reported ($0.46) EPS for the quarter, missing the Zacks' consensus estimate of ($0.36) by $0.10. The business had revenue of $16.18 million for the quarter. View SI-Bone's Earnings History.

When is SI-Bone's next earnings date?

SI-Bone is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for SI-Bone.

What guidance has SI-Bone issued on next quarter's earnings?

SI-Bone updated its FY 2019 Pre-Market earnings guidance on Thursday, January, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $67-67.3 million, compared to the consensus revenue estimate of $66.19 million.

What price target have analysts set for SIBN?

2 Wall Street analysts have issued twelve-month target prices for SI-Bone's stock. Their forecasts range from $27.00 to $27.00. On average, they expect SI-Bone's share price to reach $27.00 in the next year. This suggests a possible upside of 31.0% from the stock's current price. View Analyst Price Targets for SI-Bone.

What is the consensus analysts' recommendation for SI-Bone?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SI-Bone in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for SI-Bone.

Has SI-Bone been receiving favorable news coverage?

Press coverage about SIBN stock has trended somewhat positive recently, according to InfoTrie Sentiment. The research firm ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. SI-Bone earned a coverage optimism score of 2.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for SI-Bone.

Are investors shorting SI-Bone?

SI-Bone saw a decrease in short interest during the month of January. As of January 31st, there was short interest totalling 723,500 shares, a decrease of 6.1% from the January 15th total of 770,200 shares. Based on an average daily trading volume, of 164,600 shares, the short-interest ratio is presently 4.4 days. Approximately 4.6% of the shares of the company are short sold. View SI-Bone's Current Options Chain.

What other stocks do shareholders of SI-Bone own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SI-Bone investors own include Alibaba Group (BABA), Home Depot (HD), Honeywell International (HON), Thermo Fisher Scientific (TMO), Verizon Communications (VZ), Cisco Systems (CSCO), CSX (CSX), CVS Health (CVS), Procter & Gamble (PG) and Johnson & Johnson (JNJ).

Who are SI-Bone's key executives?

SI-Bone's management team includes the folowing people:
  • Mr. Jeffrey W. Dunn, CEO, Pres & Chairman (Age 63)
  • Dr. Mark A. Reiley M.D., Founder & Director (Age 68)
  • Ms. Laura A. Francis, Chief Financial Officer (Age 52)
  • Mr. Anthony J. Recupero, Chief Commercial Officer (Age 61)
  • Dr. Scott A. Yerby, Chief Technology Officer (Age 51)

When did SI-Bone IPO?

(SIBN) raised $84 million in an initial public offering (IPO) on Wednesday, October 17th 2018. The company issued 6,000,000 shares at $13.00-$15.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers.

Who are SI-Bone's major shareholders?

SI-Bone's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Driehaus Capital Management LLC (4.29%), State Street Corp (1.16%), Victory Capital Management Inc. (0.54%), Victory Capital Management Inc. (0.50%), Charles Schwab Investment Management Inc. (0.38%) and Renaissance Technologies LLC (0.26%). Company insiders that own SI-Bone stock include Anthony J Recupero, David P Bonita, Jeffrey W Dunn, Laura Francis, Mark A Reiley, Michael A Pisetsky, Scott A Yerby, Skyline Venture Partners V Lp and W Carlton Reckling. View Institutional Ownership Trends for SI-Bone.

Which major investors are selling SI-Bone stock?

SIBN stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Panagora Asset Management Inc., Spark Investment Management LLC, Private Ocean LLC and Bank of America Corp DE. Company insiders that have sold SI-Bone company stock in the last year include Anthony J Recupero, Jeffrey W Dunn, Laura Francis, Mark A Reiley, Michael A Pisetsky, Scott A Yerby, Skyline Venture Partners V Lp and W Carlton Reckling. View Insider Buying and Selling for SI-Bone.

Which major investors are buying SI-Bone stock?

SIBN stock was acquired by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Victory Capital Management Inc., California Public Employees Retirement System, Renaissance Technologies LLC, State Street Corp, Driehaus Capital Management LLC, UBS Group AG and Bank of New York Mellon Corp. Company insiders that have bought SI-Bone stock in the last two years include David P Bonita and Skyline Venture Partners V Lp. View Insider Buying and Selling for SI-Bone.

How do I buy shares of SI-Bone?

Shares of SIBN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is SI-Bone's stock price today?

One share of SIBN stock can currently be purchased for approximately $20.61.


MarketBeat Community Rating for SI-Bone (NASDAQ SIBN)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  62 (Vote Outperform)
Underperform Votes:  85 (Vote Underperform)
Total Votes:  147
MarketBeat's community ratings are surveys of what our community members think about SI-Bone and other stocks. Vote "Outperform" if you believe SIBN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SIBN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel